Dr. Conner Chan, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical Branch at Galveston (2008)
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 1,393
Licensed in Texas since 2012, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Medical school: University of Texas Medical Branch at Galveston
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
TX license P2424 (first issued 2012; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Baytown Dermatology PA (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,393
- Services billed
- 11,721
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 5,548 | 764 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,288 | 911 |
| Destruction of precancer skin growth, 1 growth | 1,166 | 856 |
| Established patient office or other outpatient visit, 30-39 minutes | 703 | 471 |
| Destruction of precancer skin growth, 15 or more growths | 422 | 295 |
| Destruction of skin growth, 1-14 growths | 373 | 308 |
| Biopsy of related skin growth, first growth | 339 | 307 |
| New patient office or other outpatient visit, 30-44 minutes | 170 | 170 |
| Established patient office or other outpatient visit, 10-19 minutes | 157 | 139 |
| New patient office or other outpatient visit, 45-59 minutes | 136 | 136 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 61 payments worth $1,330 in total to this clinician.
| Arcutis Biotherapeutics, Inc. | $307 |
|---|---|
| Galderma Laboratories, L.P. | $296 |
| Janssen Biotech, Inc. | $251 |
| UCB, Inc. | $150 |
| AbbVie Inc. | $128 |
| Amgen Inc. | $75.14 |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $67.80 |
| Organon LLC | $32.26 |
| Food and Beverage | $1,240 |
|---|---|
| Education | $89.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Jul 31, 2025 | Education TREMFYA · Immunology · in-kind | $89.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.